Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs. - Wikidata - awgldk - TriplyDB

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

http://www.wikidata.org/entity/Q36068258

about

Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation Role of TIM-3 in ovarian cancer.Laminins affect T cell trafficking and allograft fate.Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation.Tim-3 and its role in regulating anti-tumor immunity.Fragile TIM-4-expressing tissue resident macrophages are migratory and immunoregulatory.Regulation of T cell responses by the receptor molecule Tim-3.Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells.Tim-3 expression defines regulatory T cells in human tumors.Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model.PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection.Negative CD4 + TIM-3 signaling confers resistance against cold preservation damage in mouse liver transplantation.An obligate cell-intrinsic function for CD28 in Tregs TIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer.The influence of T cell Ig mucin-3 signaling on central nervous system autoimmune disease is determined by the effector function of the pathogenic T cells.Glycobiology of cell death: when glycans and lectins govern cell fate.Diversification and senescence of Foxp3+ regulatory T cells during experimental autoimmune encephalomyelitis.TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action.New insights into T-cell cosignaling in allograft rejection and survival.Emerging immune checkpoints for cancer therapy.Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.T Cell Cosignaling Molecules in Transplantation.Co-stimulate or Co-inhibit Regulatory T Cells, Which Side to Go?Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface.Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival.HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo.Induction, control, and plasticity of Treg cells: the immune regulatory network revised?Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interaction.Tim-3, Lag-3, and TIGIT.Immune regulation by Tim-3.Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.Common Features of Regulatory T Cell Specialization During Th1 Responses.Next generation immune-checkpoints for cancer therapy.Novel Effector Phenotype of Tim-3 Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients

P2860

Q24297200-E6412DC1-3434-4FE6-94F3-3BD250323567 Q30235023-F11A47ED-4E40-45C1-AC59-E82BDFBEB3BC Q30577194-CC8BB0CA-D167-46A9-9484-CCE12087A91C Q33650505-7FEFBC58-47A2-4DEC-A288-74E7CA480670 Q33909020-A3B26D7F-D0BA-4176-86D0-F25FF8D8EBE9 Q33944179-E9902A97-38BB-4DAA-BC83-036687E4E269 Q34017074-50662EF8-2B1E-43C7-8653-3781F057D16E Q34195216-03F7C137-DA5C-4FEC-9EAF-F21A61B25800 Q34634058-9A9E2B45-C374-4C1E-96A7-48C122C406BE Q34718313-3448B111-88F7-4350-A410-610BF9D18E34 Q34769749-E0543304-53CA-415E-B8CD-174B2BACE3FE Q35140130-8008C1B4-4BCE-430D-BAD7-842922609495 Q35637207-8505A9A8-1717-4B88-8B25-E1A457730560 Q35688947-8370761A-9D6D-4DAC-B16E-CBB1C0D3C049 Q35954111-3EE0EF5C-B906-4876-A44C-86CB5FB3F90E Q36509345-E20BCD60-1F78-45BE-ABC9-C5EFCD575A9E Q36580415-7F028635-8ED3-44EE-B92B-7FA2D6CD6E9D Q36845835-309F62FA-71CF-4F4B-817B-37918A2FFC56 Q36917904-79500FEC-6584-4257-BEDD-BB02471B0783 Q36994801-86BE439C-23C4-46C0-85EE-F5EDE22AB52E Q37178510-EFA2DE9C-912A-4F4A-A78F-43524ED98BC6 Q37729313-95677DB4-E8F8-42DF-876B-929C183D9FAB Q38309285-CCAFD2FF-3EF9-47F0-9CD4-8FF334CD9D85 Q38584979-53BE3AE6-8EBE-45E2-96BD-F037FA7C52D3 Q38837469-8C4BAD07-DB6A-4995-98EB-5CF361FB258F Q38837473-C5FFAFE6-B3D5-4568-BDD9-586D3265AD1F Q38897638-CA97398B-7C62-4D5D-BEBA-D128724C2307 Q39161011-707BF360-1A51-48AE-A26B-0DD591908B39 Q40891481-995C726B-9C49-4B0A-839E-D806402204C7 Q41049928-623D93E1-0F2E-4D18-8F0A-A7355FB91459 Q41894013-65A24EB9-8F94-41B0-A188-AAFCFE815AA6 Q42154142-CFD9C657-9341-4178-AF2F-FC4AD806E6A5 Q44661076-6F6AD55D-B017-4ABD-9FFD-D2BBAF160D86 Q46520709-AB3CCE5F-BB7F-47B5-966E-01B1C9C8A1F9 Q50125564-DFB1CCF2-ABD2-4BA0-B863-9A2A31F520B2 Q52348457-BDE3F836-B17E-42E1-B292-71262EE71F06 Q55285607-9E66B87B-EF94-4EF5-AF50-2E6468CFE867 Q55315496-BBA5D89D-970D-4E71-B7E0-DE5A7E23AD18 Q55383705-F42F48F9-E1B6-4AC8-AC2B-237E719DEFE4 Q56888845-0EF2BB34-E234-48BB-86EE-70D6E5A0B238

P2860

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

http://www.wikidata.org/entity/Q36068258

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

@ast

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

@en

type

label

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

@ast

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

@en

prefLabel

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

@ast

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

@en

P1433

Q36068258-846EE43B-CD18-4E27-90DD-92300323DAFA

P1476

Q36068258-5D87D1CC-F3F6-4256-A773-C303BEEE9420

P2093

Q36068258-0DD06BBE-9353-4611-B8CC-F1B0155D18ED

Q36068258-28065DBB-C074-4B56-8210-E6E47AABAE5C

Q36068258-40175C92-5FC2-486B-981C-FE4EADE0B963

Q36068258-75B9C334-4F53-482F-8095-0B0D5A3E4556

Q36068258-7D5BA096-07B4-4DC6-8DAA-AF4B301265E9

Q36068258-EC67F32A-E639-4E84-9B2D-FAFC43A37912

P2860

Q36068258-17CFCAA8-1B92-4378-BEC4-173313BC9518

Q36068258-1D09B908-96EA-4EFF-8A5F-F923A0443219

Q36068258-219CF5EA-A9E5-4BFD-8B62-5E4D67853F88

Q36068258-25C7D4A0-C93C-41F5-BEC1-1AB4387898D7

Q36068258-275843C1-59DD-4E7D-8C95-1E8E062A9071

Q36068258-291A84FD-7A4B-4645-B052-F697EC64E653

Q36068258-2B48E74A-D8EE-44CF-B924-F68DA8887840

Q36068258-2E72373F-2D15-40E0-85CF-11CD4982785B

Q36068258-30105D08-DEBD-4174-A6A7-D4C67424487A

Q36068258-30C2A15B-4075-44AE-8170-DE98ED368583

P304

Q36068258-49CBD844-031F-4440-B070-6F8843100454

P31

Q36068258-DD7AF055-6D2B-435B-9D85-4B166DAF75FB

P356

Q36068258-8CEBD390-CB9F-4F83-A8FA-5D0D685DF160

P407

Q36068258-DDDDD8EA-B9E0-4CF1-9826-C7FC726B7C25

P433

Q36068258-6D97761E-5DA7-474E-8377-EA1D0302BD3E

P478

Q36068258-85D83679-0F67-485C-A19D-40356F2BE5B2

P50

Q36068258-4E2A4A8D-8893-4E0A-B7DD-F78D22A935B5

P577

Q36068258-4C4B43C7-D397-4863-BE64-966A6EA1AAF5

P698

Q36068258-4551FB04-D45C-4BEA-B145-0BF642D32066

P932

Q36068258-CE00A0E7-7ECE-48C9-96F8-97D74B782DDE

P356

P1433

Journal of Clinical Investigation

P1476

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

@en

P2093

Laurence A Turka

http://www.w3.org/2001/XMLSchema#string

Rafael Larocca

http://www.w3.org/2001/XMLSchema#string

Shipra Gupta

http://www.w3.org/2001/XMLSchema#string

Terry B Strom

http://www.w3.org/2001/XMLSchema#string

Vijay K Kuchroo

http://www.w3.org/2001/XMLSchema#string

Wenda Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry

Dysregulated T cell expression of TIM3 in multiple sclerosis

T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

Interleukin-17 and type 17 helper T cells

Regulatory T cells exert checks and balances on self tolerance and autoimmunity

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

P304

2395-2404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI45138

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Thornley

P577

2012-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22684103

http://www.w3.org/2001/XMLSchema#string

P932

3386804

http://www.w3.org/2001/XMLSchema#string